The U.S. Market for Rx to OTC Switches, 6th Edition

Date: January 11, 2013
Pages: 290
Price:
US$ 3,995.00
License [?]:
Publisher: Kalorama Information
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: UD9E5ED6E1CEN
Leaflet:

Download PDF Leaflet

The U.S. Market for Rx to OTC Switches, 6th Edition
The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available by prescription. This report represents the six time that Kalorama Information has analyzed the market for drugs with switched ingredients in detail. The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes switched to OTC; product demand; economic conditions and several other factors.

The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available. These include:
  • Allergy, Cough, Cold, and Sinus Products
  • Analgesics, NSAIDs, and Pain Treatments
  • Anti-Infectives
  • Gastrointestinal Drugs
  • Hair Loss Products
  • Hormones
  • Oral Care
  • Rectal Ointments
  • Sleep-aids
  • Smoking Cessation
  • Weight Loss
In addition to the areas with switches in place, Kalorama Information has identified other areas which may be open to Rx-to-OTC switches in the future. These include:
  • Blood Products
  • BPH Treatments
  • Cholesterol-reducing Drugs
  • Hormone Replacement Therapies
  • Migraine Treatments
  • Osteoporosis Treatments
  • Overactive Bladder
  • Sexual Dysfunction/ Erectile Dysfunction
The report covers OTC drugs that were once only available by prescription due to either the active ingredient or dosage of the drug. Current and historical revenues for product segments include both the switched brands and OTC drugs containing switched ingredients. Forecasted data includes current products and forecasted switches which are outlined in the report.

The report includes statistical information for conditions and diseases affecting the U.S. population, including detail discussions, tables and figures. Each segment provides an overview, descriptions of products on the market, market estimates and forecasts, and competitive analysis of leading providers. In addition to above-mentioned information, the report includes current issues and trends affecting the industry and identifies trends that may arise in the future.

All product areas contribute to the growth and development of the OTC market; however, new product development and additional regulatory review and approval of new OTC drug classifications, specifically in areas such as allergy treatments, cholesterol-reducing drugs, urinary disorders treatments and hormones treatments are expected to make the most impact.

There are several companies that compete heavily in this market and use the Rx-to-OTC switch as a major part of their life-cycle management arsenal. Companies involved in the Rx-to-OTC switched market include brand, generic, and private label manufacturers. Competition will likely continue to be moderate in the OTC market, especially with the patent expiration of key products nearing. Consolidation remains a major factor in this market. Most major players have made a significant acquisition or formed a strategic alliance to increase revenues and drive growth. Product innovation, line extensions and strong promotional support are a few of the top strategies for growth in this industry.

Leading competitors offering key brand products are provided in this report. These companies include:
  • Bayer Healthcare
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • Insight Pharmaceuticals
  • Johnson & Johnson
  • Merck
  • Novartis
  • Pfizer
  • Prestige Brands
  • Procter & Gamble
  • Reckitt Benckiser
  • Sanofi (Chattem)
  • TEVA
CHAPTER ONE: EXECUTIVE SUMMARY

Scope and Methodology
Size and Growth of the Market
Issues and Trends Affecting the Rx-to-OTC Switches Market
Leading Competitors

CHAPTER TWO: INTRODUCTION

Overview of the Over-the-Counter Market
Development of the Rx-to-OTC Drug Market
Rx-to-OTC Industry
  Economic Indicators
  The FDA and Rx-to-OTC Switches

CHAPTER THREE: ALLERGY, COUGH, COLD, AND SINUS PRODUCTS

Overview
  Antihistamines
  Decongestants
  Cough Preparations
  Mast Cell Stabilizers
  Ophthalmic Preparations
Description of Conditions
  Allergic Rhinitis
  Common Cold
  Sinusitis
  Hives
  Ocular Allergies
Product Analysis
  Switched Products
  Antihistamines
  Decongestants
  Cough Preparations
  Mast Cell Stabilizers
  Ophthalmic Preparations
  Prescription Products with Anticipated OTC Approvals
  Xyzal
  Clarinex
  Astelin Nasal Spray
  Atrovent Nasal Spray
  Flonase
  Nasacort AQ
  Rhinocort
  Nasonex
  Beconase AQ
Market Analysis
  Market Size and Forecast
  Competitive Analysis

CHAPTER FOUR: ANALGESICS AND OTHER PAIN RELIEVERS

Overview
  Analgesics
  Nonsteroidal Anti-inflammatory Drugs
  Topical Pain Relievers and Other Similar Products
Description of Conditions
  Pain
  Inflammation
Product Analysis
  Switched Ingredients
  Antipruritic
  Internal analgesic/antipyretic
  Oral anesthetic
  Prescription Products with Anticipated OTC Approvals
  Nonsteroidal anti-inflammatory drugs
  Voltaren (diclofenac)
  Diflunisal
  Etodolac
  Nabumetone
  Feldene (piroxicam)
  Migraine treatments
  Axert
  Imitrex
  Maxalt
  Zomig
  Other Migraine Treatments
  Market Analysis
  Market Size and Forecast
  Competitive Analysis

CHAPTER FIVE: ANTI-INFECTIVES

Overview
  Antibiotics
  Antifungals
  Antivirals
  Antiparasitics
Description of Conditions
  Vaginal Infections
  Athlete’s Foot
  Jock Itch
  Ringworm
  Dandruff
  Scabies and Pediculosis
  Pinworm
  Fungal Nail Infections
Product Analysis
  Switched Ingredients
  Antifungals
  Anthelmintics
  Antimicrobials
  Pediculicides
  Prescription Products with Anticipated OTC Approvals
  Antivirals
  Zovirax
  Valtrex
  Denavir
  Famvir
  Influenza Antivirals
  Antibiotics
  Antifungals
Market Analysis
  Market Size and Forecast
  Competitive Analysis

CHAPTER SIX: GASTROINTESTINAL DRUGS

Overview
Description of Conditions
  Nausea
  Diarrhea
  Constipation
  Heartburn
  Acid reflux
Product Analysis
Switched Ingredients
  Histamine H2 Inhibitors
  Proton Pump Inhibitors
  Antidiarrheals
  Laxatives
  Antiemetics
Prescription Products with Anticipated OTC Approvals
  Proton Pump Inhibitors
  Nexium
  Protonix
  Aciphex
  Mucosal Protectants
  Antiemetics
Market and Competitive Analysis
  Market Size and Forecast
  Competitive Analysis

CHAPTER SEVEN: SMOKING CESSATION PRODUCTS

Overview
Description of Conditions
  Lung Cancer and Tobacco Use
Product Analysis
  Switched Ingredients
  Prescription Products with Anticipated OTC Approvals
  Nicotrol
  Chantix
Market Analysis
  Market Size and Forecast
  Competitive Analysis

CHAPTER EIGHT: OTHER DRUG CLASSIFICATIONS

Overview
  Contraceptives
  Dental Rinses and Fluorides
  Hair Growth Products
  Rectal Ointments
  Sleep Aids
  Weight Management
Description of Conditions
  Pregnancy
  Global Birth Rates
  Abortion Rates
  Contraceptive Use
  Dental carries
  Hereditary Hair Loss
  Hemorrhoids
  Sleeplessness
  Obesity
  Conditions with Possible Future OTC Treatments
  Acne Vulgaris
  Benign Prostate Hypertrophy (BPH)
  Elevated Cholesterol
  Erectile Dysfunction
  Menopause and Hormone Replacement
  Menorrhagia
  Osteoporosis
  Urinary Incontinence/Overactive Bladder
  Product Analysis
  Switched Ingredients
  Contraceptives
  Dental rinses and fluoride
  Hair growth
  Rectal ointments
  Sleep aids
  Weight Management
  Prescription Products with Anticipated OTC Approvals
  Acne Treatments
  Cholesterol-reducing Drugs (antilipidemics)
  Blood Products
  BPH
  Erectile Dysfunction
  Hair Loss Treatment
  Hormone-Replacement Therapies (HRT)
  Osteoporosis Treatments
  Overactive Bladder
  Sleep Aids
Market Analysis
  Current Market Segments
  Short-Term New Product Segment Development; 2013-2017
  Product segments with short-term potential include:
  Antilipidemics
  BPH Treatments
  Hormone Replacement Therapy and Osteoporosis Treatments
  Overactive Bladder Treatments
  New Product Segments; Post 2017
  Sexual Dysfunction
  Competitive Analysis

CHAPTER NINE: TOTAL MARKET SUMMARY

Overview
Total market Size and Forecast
Competitive Analysis

CHAPTER TEN: ISSUES AND TRENDS AFFECTING THE RX-TO-OTC MARKET

Introduction
Regulatory Authorities
Additional Drug Access
Using Technology or Pharmacies for Nonprescription Drug Access
  Physicians and Increasing Nonprescription Drug Access
Impact on the Consumer
  Online Resources for Health Information
  OTC Availability
Insurance Issues and Reimbursement for OTC Drugs
  Health Insurance Trends in the United States
  Healthcare Flexible Spending Accounts, Health Savings Accounts and OTC Medicines
Changing the Pharmacist's Role
Impact on the Prescription Drug Manufacturer
Strategies for Continued Product Growth
  Mergers and Acquisitions
  Procter & Gamble and Teva Pharmaceutical Industries
  Sanofi and Chattem Consumer
  Schering-Plough and Merck & Co
  Wyeth and Pfizer
  Reckitt Benckiser and Adams Respiratory Therapeutics
  Bristol-Myers Squibb and Novartis AG
  Johnson & Johnson and Pfizer
  Reckitt Benckiser and Boots Healthcare
  Bayer and Roche
Strategies in Switching
  Dual Status Switching
  Generic Competition
  Direct-to-Consumer Advertising
Patent Expiration
International Trends in Rx-to-OTC Switches
Consumers around the World
Streamlined Access to OTC Drug Products in Canada
Prescription vs Over-the-Counter Industry
World Health, Demographics and Life Expectancy
  Life Expectancy
Birth Rates

CHAPTER ELEVEN: COMPANY PROFILES

Introduction
Bayer Healthcare
Boehringer Ingelheim
GlaxoSmithKline
Insight Pharmaceuticals
Johnson & Johnson
Merck & Co
Novartis
Pfizer
Prestige Brands
Procter & Gamble
Reckitt Benckiser
Sanofi/Chattem
TEVA

APPENDIX: COMPANY DIRECTORY

Ask Your Question

The U.S. Market for Rx to OTC Switches, 6th Edition
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: